Mechanisms of NK Cell Activation and Clinical Activity of the Therapeutic SLAMF7 Antibody, Elotuzumab in Multiple Myeloma
about
Mechanisms of NK Cell Activation and Clinical Activity of the Therapeutic SLAMF7 Antibody, Elotuzumab in Multiple Myeloma
description
scientific article published on 05 November 2018
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована у 2018
@uk
name
Mechanisms of NK Cell Activati ...... Elotuzumab in Multiple Myeloma
@en
Mechanisms of NK Cell Activati ...... Elotuzumab in Multiple Myeloma
@nl
type
label
Mechanisms of NK Cell Activati ...... Elotuzumab in Multiple Myeloma
@en
Mechanisms of NK Cell Activati ...... Elotuzumab in Multiple Myeloma
@nl
prefLabel
Mechanisms of NK Cell Activati ...... Elotuzumab in Multiple Myeloma
@en
Mechanisms of NK Cell Activati ...... Elotuzumab in Multiple Myeloma
@nl
P2860
P921
P356
P1476
Mechanisms of NK Cell Activati ...... Elotuzumab in Multiple Myeloma
@en
P2093
Kerry S Campbell
Tatiana Pazina
P2860
P356
10.3389/FIMMU.2018.02551
P407
P50
P577
2018-11-05T00:00:00Z